Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice
about
Adaptive immunity in the liverPrimary biliary cirrhosis: From bench to bedsidePrimary biliary cirrhosis: Clinical and laboratory criteria for its diagnosisGenome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility lociThe Biology of Autoimmune Response in the Scurfy Mice that Lack the CD4+Foxp3+ Regulatory T-CellsRegulation of multi-organ inflammation in the regulatory T cell-deficient scurfy mice.Genetic dissection of granulomatous enterocolitis and arthritis in the intramural peptidoglycan-polysaccharide-treated rat model of IBD.CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis.Differential modulation by IL-17A of Cholangitis versus Colitis in IL-2Rα deleted mice.Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitisRole of cholangiocytes in primary biliary cirrhosis.Liver immunology.Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.Potential role of NK cells in the pathogenesis of inflammatory bowel disease.Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis.Pathological features of new animal models for primary biliary cirrhosis.Role of autoimmunity in primary biliary cirrhosis.Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens.Th17 cells and their associated cytokines in liver diseases.Role of the anion exchanger 2 in the pathogenesis and treatment of primary biliary cirrhosis.Genetics in PSC: what do the "risk genes" teach us?Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver DiseasesAnimal models of primary biliary cirrhosis.Increased ΤGF-β3 in primary biliary cirrhosis: an abnormality related to pathogenesis?Proteomic analysis reveals distinctive protein profiles involved in CD8+ T cell-mediated murine autoimmune cholangitis.Regulatory T cells with a defect in inhibition on co-stimulation deteriorated primary biliary cholangitis.The CXC Chemokine Receptor 3 Inhibits Autoimmune Cholangitis via CD8+ T Cells but Promotes Colitis via CD4+ T Cells.
P2860
Q26753195-7BD592B0-D7C2-451A-BCC8-9DF5D14F5566Q26799419-0CF1FEB3-E495-4B64-BF86-DF77C171D0CDQ26992087-4DA0C00E-229A-40B2-BBF4-686B76589587Q28943478-F0E04CC4-CEBB-4667-A20C-F429534232A7Q30413157-8F190C64-BF16-44CD-9186-82E9A6A6F7C3Q30440063-B01BD0D9-D334-4072-B007-0236664A3DA0Q33926900-8FDC653F-0A39-449F-A76B-7DA4B8BB82B3Q34027799-21C22290-BFDB-4F84-97AC-7526A982E6E8Q34061724-3C6C6752-B0DB-4296-B545-78F205FECDA3Q34116480-BE40442C-1CC4-40CA-B1C7-D2BAE114E7E5Q34276575-15ED1545-7930-4CED-BBC5-EE154A6C2CE0Q34359990-E8C9D90C-CC5D-401E-A8EE-76227959E672Q34482519-32520DB9-C7CB-4A6D-ADFC-79B36AE471BDQ35043975-D96BEA16-5FB2-4FC1-8C00-12327F349B1FQ35148923-CF966C62-2CD4-4B0F-867A-565EF2097116Q35203353-DB0D7CC1-0742-4D90-B286-F11848B9896AQ36529131-B6E81820-65E4-4F93-9679-3F17FE867263Q36708065-06FFC74B-D13F-42E2-8966-73330D214EC7Q37067749-436CC28F-59B7-4C19-996F-1BDD979B7029Q37892296-85EB2B22-B631-4739-83CD-1E04A7A2A151Q38204911-9B685829-3698-4697-B8EC-4E9701C878BAQ38244716-F53B4899-69C6-47F3-A711-E8C8A9E3A98CQ38543052-5CB0FE40-D2C3-49A5-B5AE-E72EADED4554Q41221983-F11B029D-D6D1-4DF2-96F4-0117F01B7DB0Q41763785-9D691420-4138-44F9-8972-8626B558E10EQ48156075-FA0331FA-4013-4794-A7A9-92F8E899D884Q50129651-74C54D0D-2FE7-4846-A187-0FB0495D0E9CQ55263086-9149DD68-5E7B-4640-B447-CCD1F3E7DD9D
P2860
Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differential mechanisms in the ...... disease in interleukin-2Ralpha
@nl
Differential mechanisms in the ...... interleukin-2Ralpha(-/-) mice
@en
type
label
Differential mechanisms in the ...... disease in interleukin-2Ralpha
@nl
Differential mechanisms in the ...... interleukin-2Ralpha(-/-) mice
@en
prefLabel
Differential mechanisms in the ...... disease in interleukin-2Ralpha
@nl
Differential mechanisms in the ...... interleukin-2Ralpha(-/-) mice
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Differential mechanisms in the ...... interleukin-2Ralpha(-/-) mice
@en
P2093
Ian Mackay
Koichi Tsuneyama
Weici Zhang
William M Ridgway
Yuki Moritoki
P2860
P304
P356
10.1002/HEP.22591
P407
P577
2009-01-01T00:00:00Z